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Abstract
Deeper exploration of uncharacterized Gcn5-related N-acetyltransferases has the potential
to expand our knowledge of the types of molecules that can be acylated by this important
superfamily of enzymes and may offer new opportunities for biotechnological applications.
While determining native or biologically relevant in vivo functions of uncharacterized
proteins is ideal, their alternative or promiscuous in vitro capabilities provide insight into
key active site interactions. Additionally, this knowledge can be exploited to selectively
modify complex molecules and reduce byproducts when synthetic routes become
challenging. During our exploration of uncharacterized Gcn5-related N-acetyltransferases
from Pseudomonas aeruginosa, we identified such an example. We found that the PA3944
enzyme acetylates both polymyxin B and colistin on a single diaminobutyric acid residue
closest to the macrocyclic ring of the antimicrobial peptide and determined the PA3944
crystal structure. This finding is important for several reasons: 1) to our knowledge this is
the first report of enzymatic acylation of polymyxins and thus reveals a new type of
substrate that this enzyme family can use, 2) the enzymatic acetylation offers a controlled
method for antibiotic modification compared to classical promiscuous chemical methods,
and 3) the site of acetylation would reduce the overall positive charge of the molecule,
which is important for reducing nephrotoxic effects and may be a salvage strategy for this
important class of antibiotics. While the physiological substrate for this enzyme remains
unknown, our structural and functional characterization of PA3944 offers insight into its
unique non-canonical substrate specificity.
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Introduction
Gcn5-related N-acetyltransferases (GNATs) are a fascinating family of enzymes that
acylate a variety of substrates ranging from small molecules to macromolecules. Members
of this family are well known for their roles in aminoglycoside antibiotic resistance, histone
modification, protein acetylation, xenobiotic metabolism, and other cellular processes
[reviewed in1,2]. They accomplish this by acylating a primary amine of an acceptor
molecule with a donor molecule like acetyl-coenzyme A (AcCoA). While N-acylation is
most common, O-3,4 and S-acylation5 can also occur. The structures and functions of
GNATs from all domains of life have been extensively studied; however, a significantly
large number of them remain uncharacterized. On average, most organisms have
approximately 20 GNATs encoded within their genomes; however, this number varies by
organism and can be much lower or much greater.2 For instance, Campylobacter jejuni has
4 genes that encode GNATs, while Streptomyces coelicolor has 72.2 Thus, not all GNATs
are conserved across organisms, which implies that the presence of certain GNATs may be
tailored to the individual needs of the organism.
To gain a deeper understanding of the diversity of GNAT functions within a single
bacterium, we have selected Pseudomonas aeruginosa PAO1 as a model system to further
study GNATs of unknown function. The rationale for this selection is the following. First,
this bacterium is found in a variety of environments, including in water,6 in soil near the
roots of plants,7 on medical devices such as catheters,8 and in the lungs of cystic fibrosis
patients.9 It is a highly antibiotic-resistant bacterium that causes severe nosocomial
infections, especially in immunocompromised individuals.10 Thus, knowledge gained
about GNATs from this organism has important implications in agriculture and human
disease as it is one of the ESKAPE11 pathogens. Second, it is genetically tractable, i.e. it
can be manipulated to explore the effects of deleting or overexpressing a gene in the
organism in the laboratory, and an entire curated database (Pseudomonas Genome DB;
http://www.pseudomonas.com/12) is maintained to house information related to its study.
Finally, P. aeruginosa contains 36 GNATs in its genome (Supplemental Table 1) and the
majority of them have been annotated as hypothetical proteins or as proteins of unknown
function. Nine of them have been structurally characterized (Supplemental Table 1), but
the depth of functional information is even less.
Due to the diversity of functions of GNATs already identified to date, we expect that
exploring uncharacterized GNAT proteins will expand the repertoire of substrates utilized
by members of this family of proteins. Additional benefits to studying GNATs of unknown
function include improving their functional annotation across diverse genomes and
identifying new targeted reactions that can be utilized for enzyme-mediated chemical
synthesis or biotechnological applications. In an effort to expand our knowledge of the
functional space of GNATs, we previously designed a broad-substrate screening assay to
identify potential lead compounds to further explore the substrate specificity and catalytic
activity of uncharacterized GNATs.13 While this screen has its limitations, it does provide
a starting point for further GNAT functional characterization.
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Here, we focused on the structural and kinetic characterization of the PA3944 enzyme. We
previously screened this enzyme against our panel of potential substrates and found it could
acetylate polymyxin B and E (colistin) antimicrobial peptide antibiotics as well as the
dipeptide aspartame13. Since the enzymatic activity toward polymyxins is novel, we
concentrated our structural and functional characterization of PA3944 on its ability to
acetylate polymyxins. These antibiotics have five potential sites for N-acetylation;
therefore, we sought to further explore whether the enzyme was specific for one site or if
it was promiscuous in its acetylation activity. While we do not believe the native function
of this enzyme is to modify polymyxin antibiotics, we do think we can uncover clues about
PA3944 substrate specificity by studying how this enzyme modifies these compounds.
Since this is the first description of a polymyxin antibiotic modifying enzyme, we also
determined its crystal structure. Collectively, our study provides structural and functional
information about this enzyme, which will be useful for: 1) identifying other potential
polymyxin-modifying GNAT enzymes and 2) engineering GNATs to selectively modify
these antibiotics to salvage them in the clinic or be used for other biotechnological
applications.
Methods
Clone
The PA3944 gene (UniProtKB Q9HX72) from Pseudomonas aeruginosa was subcloned
into the p11 vector as described previously.14 It contains an ampicillin resistance cassette
and gene expression is under control of the T7 promoter. Protein produced with this system
contains an N-terminal methionine residue followed by a three amino acid spacer (GSS), a
hexahistidine tag, another four amino acid spacer (SSGR), a tobacco etch virus (TEV)
protease cleavage site (ENLYFQ/G), and a histidine spacer residue (i.e.
MGSSHHHHHHSSGRENLYFQGH) prior to the first methionine of the PA3944 protein
sequence.
Protein expression and purification for kinetics and mass spectrometry assays
Cell growth and protein expression—The clone containing the PA3944 gene was
transformed into E. coli BL21(DE3) competent cells and was stored as a glycerol stock at
-80°C until ready to use. A 5 ml starter culture of lysogeny broth (LB) media with 100
g/ml ampicillin was then inoculated and grown overnight at 37°C with shaking at 200
rpm on a benchtop shaker. The next day, 2.5 ml of starter culture was added to 250 ml of
Terrific Broth (TB) with 100 g/ml ampicillin in a 2 L glass Erlenmeyer flask and shaken
at 200 rpm at 37°C until the OD600nm reached 0.6-0.8. Cells were placed on ice until cool
and then 0.5 mM isopropyl β-D-1-thiogalactopyranoside (IPTG) was added to induce
protein expression at RT with shaking at 150 rpm overnight. Cells were harvested by
centrifugation at 2200 x g for 30 min at 4°C, and the pellet was resuspended in 37.5 ml of
cold lysis buffer (10 mM Tris-HCl pH 8.3, 500 mM NaCl, 5 mM imidazole, 5% glycerol,
and 5 mM beta-mercaptoethanol (BME)), sonicated on ice for 5 min, and then stored at 80°C until ready to purify.
Protein purification and tag cleavage—The lysed cells were thawed and centrifuged at
25,000 x g for 45 min in a Sorvall SS-34 rotor at 4°C. The crude extract (supernatant) was
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loaded onto a 1 ml HisTrap FF nickel-affinity column (GE Healthcare) that had been
equilibrated with buffer A (10 mM Tris-HCl pH 8.3, 500 mM NaCl, and 5 mM BME) on
an ÄKTA Start FPLC (GE Healthcare). Afterwards, the column was washed with 5 CVs
of 5% buffer B (10 mM Tris-HCl pH 8.3, 500 mM NaCl, 5 mM BME, and 500 mM
imidazole), and protein was eluted with 100% buffer B over 5 CVs. To remove imidazole,
we performed a buffer exchange of the eluted protein into buffer A using a PD-10 gravity
flow column (GE-Healthcare). Finally, we concentrated the protein using a 10K MWCO
Sartorius VivaSpin concentrator. To remove the polyhistidine tag, 5 mg of protein was
incubated with TEV protease (previously purified in our laboratory using the same protocol
but stored in 10 mM Tris-HCl pH 8.3, 500 mM NaCl, 5 mM BME, 2 mM EDTA, 5 mM
DTT, and 50% glycerol) in a 20:1 ratio at 4°C overnight in cleavage buffer (50 mM Tris
pH 8.3, 1 mM DTT, 300 mM NaCl, 5% glycerol) in a 15 ml 10K MWCO Slide-a-Lyzer
Mini-dialysis device (Thermo Fisher Scientific). Cleavage buffer was exchanged once after
2 hrs of dialysis. (We chose incubation for cleavage at 4°C because at higher temperatures
all of the protein precipitated). The next morning, the dialysate was centrifuged at 12,000
x g for 10 min at 4°C and the supernatant was then loaded onto the affinity column
previously equilibrated with buffer A. The cleaved protein was eluted with a gradient of 030% buffer B exchanged into buffer without BME (10 mM Tris-HCl pH 8.3 and 500 mM
NaCl) because the BME interferes with the colorimetric enzyme kinetic assay. Protein was
stored in aliquots at -80°C. Under these storage conditions, protein was stable for at least
1 year and no change in enzymatic activity was observed.
Protein crystallization and size-exclusion chromatography
Detailed methods for protein crystallization and size-exclusion chromatography can be
found in Supplemental Information.
Data collection and structure determination
Diffraction data were collected at 100 K at the LS-CAT 21 ID-G (wavelength 0.97856 A,
12670 eV; PDB ID 6edd) and SBC-CAT 19-ID (0.97926 A, 12661 eV; PDB ID 6edv)
beamlines at the Advanced Photon Source at Argonne National Laboratory. Data were
processed with HKL-200015 and structure solution and model building were performed
with HKL-300016 coupled with MOLREP,17 BUCCANEER,18 and Fitmunk.19 Models
were further refined with REFMAC520 and rebuilt with COOT.21 The quality of the models
were assessed with Molprobity22 and wwPDB Validation Service.23 Molecular replacement
was using PDB ID: 3fbu (UniProt ID: Q81Q99) as the search model. All structures have
been deposited into the Protein Data Bank (PDB) with the following accession codes: 6edv
and 6edd (Table 1) and diffraction images have been deposited into the Integrated
Resource
for
Reproducibility
in
Macromolecular
Crystallography24
(proteindiffraction.org)
with
the
following
identifiers,
respectively:
doi.org/10.18430/m36edd and doi.org/10.18430/m36edv.
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Table 1. Data collection and refinement statistics for PA3944 structures.
PDB ID
Diffraction images DOI

6edd

6edv

Data collection
Beamline

LS-CAT 21 ID-G

SBC-CAT 19 ID

Resolution (Å)

1.55
(1.55-1.58)

1.35
(1.35-1.37)

Space group

P1

P212121

Wavelength (Å)

0.97856

0.97926

a, b, c (Å)

36.45, 44.17, 60.12 36.44, 44.03, 111.64

α, β, γ (o)

81.88, 73.32, 89.94

90, 90, 90

Completeness (%)

96.2 (93.5)

100.0 (99.7)

Observed reflections

121370

558894

Unique reflections

49684

40378

<I> / <σ I>

21.3 (1.9)

46.4 (2.2)

CC1/2 last shell

0.77

0.68

Redundancy

2.4 (2.1)

13.8 (4.6)

Rmerge

0.053 (0.397)

0.122 (0.778)

Wilson B factor (Å2)

15.7

13.9

Refinement
Rwork / Rfree

0.166 / 0.194

0.133 / 0.162

Bond lengths rmsd (Å)

0.008

0.013

Bond angles rmsd (Å)

1.4

1.6

Mean B value (Å2)

20

19

Number of protein atoms

3125

1513

6

Number of water atoms

476

155

Number of ligands / ions atoms

130

57

Clashscore

2.5

0.98

Clashscore percentile (100)

99

99

Rotamer outliers (%)

0.00

0.00

Ramachandran outliers (%)

0.00

0.00

Residues with bad bonds /
angles (%)

0.00 / 0.05

0.00 / 0.00

MolProbity score

1.03

0.79

*Values in parentheses refer to the highest resolution shell.
Enzyme kinetics assays for colorimetric method and mass spectrometry
Steady-state enzyme kinetic assays—All kinetic assays were performed in triplicate using
the previously described discontinuous colorimetric method13 with minor modifications.
Briefly, all reactions were performed in 50 mM Tris-HCl pH 8.0 except for pH studies
where the buffer was 50 mM Bis-Tris-propane at pH 6.5, 7.0, 8.0, 9.0, or 9.5 in a total
volume of 50 l for 10 min at 37°C and were initiated with 10 l of enzyme. Reactions
were terminated using 50 l of 100 mM Tris-HCl pH 8.0 and 6 M guanidine HCl to
denature the protein and then 200 l of Ellman’s reagent in buffer (0.2 mM 5,5’dithiobis(2-nitrobenzoic acid) (DTNB), 100 mM Tris-HCl pH 8.0, and 1 mM EDTA) was
added to each sample and incubated at RT prior to measuring the absorbance at 415nm
with a fixed wavelength filter on a BioTek ELx808 microplate reader. Each molecule of
CoA produced during the reaction reacts with one molecule of (DTNB), which forms a 2nitro-5-thiobenzoate (TNB2-) anion under basic conditions that absorbs at 415 nm. CoA
standards (2.5 and 5 nmol) were used to determine the response factor for TNB2- at 415
nm, which was used to convert TNB2- absorbance to the number of nmols of CoA product
produced during the enzymatic reaction. One unit of enzymatic activity is defined as 1
mol of TNB2- produced per min. Kinetic parameters were determined by fitting data to
the Michaelis-Menten equation using Origin 2017 software. Details of the concentrations
of donor (AcCoA) and acceptor substrates used for each assay are described below.
The PA3944 enzyme was screened against a panel of the following compounds in TrisHCl pH 8.0 buffer to determine its substrate specificity and promiscuity: L-glutamate, Laspartate, taurine, carnosine, beta-alanine, aspartame, glycine, L-alanine, L-2,3diaminopropionic acid (DAP), colistin, polymyxin B, L-2,4-diaminobutyric acid (Dab), Lornithine, and L-lysine. Each reaction was performed in the presence of 0.5 mM AcCoA,
5 mM compound and 0.91 M enzyme. Substrate saturation curves were produced using
7

0.64 M of tagged or cleaved PA3944 enzyme. The tagged enzyme was used for substrate
screening assays and pH studies, while the cleaved protein was used for substrate saturation
curves where kinetic parameters were determined in Table 2. For polymyxin B, colistin,
and Dab substrate saturation curves AcCoA concentration was held constant at 0.5 mM
while acceptor substrate was varied from 0-10 mM for polymyxin B and colistin, and 0-20
mM for Dab. For AcCoA substrate saturation curves, polymyxin B or colistin was held
constant at 5 mM while AcCoA was varied from 0-2 mM.
Table 2. Comparison of kinetic parameters for tagged and cleaved PA3944 enzyme.
PA3944
Enzyme

Tagged

Cleaved

Substrate
Polymyxin B (constant [AcCoA])a
Colistin (constant [AcCoA])a
DAB (constant [AcCoA])a,b
AcCoA (constant [Polymyxin B])c
AcCoA (constant [Colistin])c
Polymyxin B (constant [AcCoA])a
Colistin (constant [AcCoA])a
DAB (constant [AcCoA])a,b
AcCoA (constant [Polymyxin B])c
AcCoA (constant [Colistin])c

KM
(mM)
2.57 ± 0.23
2.28 ± 0.17
8.60 ± 1.59
0.118 ± 0.028
0.105 ± 0.017
4.00 ± 0.32
2.50 ± 0.13
10.0 ± 1.2
0.137 ± 0.020
0.118 ± 0.021

kcat
(s-1)
0.653
0.672
0.264
0.602
0.471
0.923
0.894
0.391
0.610
0.456

kcat/KM
(M-1s-1)
2.54 x 102
2.95 x 102
30.7 x 101
5.10 x 103
4.49 x 103
3.65 x 102
3.58 x 102
3.91 x 101
4.45 x 103
3.86 x 103

a

The concentration of AcCoA was held constant at 0.5 mM while the acceptor substrate(s)
were varied.
b
At DAB concentrations higher than 10 mM substrate inhibition was observed; therefore,
kinetic parameters were calculated based on data collected from 0-10 mM DAB.
c
The concentration of polymyxin B or colistin was held constant at 5 mM while the
concentration of AcCoA was varied.

Enzymatic assays for mass spectrometric analysis—Enzymatic assays were performed for
1 hr at 37°C in triplicate in a 100 l reaction volume in the presence of 50 mM Tris-HCl
pH 8.0, 1 mM AcCoA, 1 mM of either polymyxin B or colistin, and 0.64 M of tagged
PA3944 enzyme. Control reactions were performed in absence of enzyme. Reactions were
terminated by adding 50% methanol to the reaction mixture and then frozen and stored at
-80°C. Reaction products were analyzed by mass spectrometry as described below.
Mass spectrometry
Reaction mixtures were extracted by solid phase extraction prior to mass spectrometry
analysis. They were then combined with 450 l of trimethylamine acetate pH 8.0, loaded
onto a Waters Corp HLB Oasis solid phase extraction cartridge (6 ml, 200 mg) and washed
with 5 ml of 100 mM triethyl acetate pH 8.0 and 5 ml of distilled water. The peptides were
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eluted with 5 ml of a 70:30 acetonitrile:water solution and evaporated to near dryness in a
Speedvac evaporator. The residue was dissolved in a 75% methanol:water solution for
direct infusion into the mass spectrometer. Molecular weight and product ion mass spectra
were acquired with a ThermoFinnigan Advantage (San Jose, CA) LCQ ion trap mass
spectrometer using electrospray ionization (ESI) in the positive ion mode. The tandem
mass spectra energy parameter was set to 50-60% of its maximum value for fragmentation
of all the singly-protonated peptides in this study. Mass spectra of all the peptide ions were
acquired by direct infusion of the 3:1 methanol:water mixture. The capillary temperature
was 200C and the spray voltage was 4.5 kV. Molecular weight and product ion spectra
were acquired from each reaction mixture and are shown in Supplemental Information.
Results and Discussion
PA3944 genomic context and protein properties
The PA3944 gene from P. aeruginosa PAO1 lies within a five-gene operon (PA3941PA3945) that encodes four hypothetical proteins and one predicted acyl-CoA thioesterase
II (tesB). Two of these hypothetical proteins (PA3944 and PA3945) are predicted to have
a GNAT domain, but their function is unknown and to our knowledge they have not been
previously studied. The organization of this operon is conserved in P. aeruginosa strains
PAO1 (an opportunistic pathogen and widely studied laboratory strain), DK2 (isolated
from Danish Cystic Fibrosis patients), M18 (found in the sweet melon rhizosphere and
produces anti-fungal compounds), and LESB58 (a hypervirulent Cystic Fibrosis isolate
from Liverpool). The PA3944 gene encodes a 21.9 kDa protein with a pI of 5.32 and is
found in both pathogenic and nonpathogenic strains of Pseudomonas in 289 genera.25
3D crystal structure of PA3944
We previously screened the PA3944 protein against a panel of potential substrates and
found the enzyme exhibited the highest activity toward aspartame, polymyxin B and
colistin (polymyxin E).13 The rationale for including these compounds in the screening
assay was that they were relatively inexpensive peptides with several potential sites for Nacylation. Due to the unusual substrate specificity of PA3944 exhibited toward polymyxin
B and colistin, we sought to determine its crystal structure to learn more about how these
antibiotics become acetylated. To begin, we screened this protein for crystals in the
presence and absence of AcCoA/CoA and a variety of substrates identified from our
previous broad-substrate screening assay.13 Two structures of PA3944 with CoA were
determined in different space groups: P212121 with a monomer in the asymmetric unit,
(PDB: 6edv) and P1 with two monomers in the asymmetric unit (PDB: 6edd) (Table 1).
The PA3944 protein structure consists of five α-helices that surround an antiparallel βsheet formed by six β-strands (Figure 1), which is a typical signature of GNATs26. The
canonical V-like splay is formed between β-strands B and C, and the topology of the
PA3944 structure is similar to that of the PA4794 GNAT we studied previously.27 CoA
was modeled into the electron density found between helices α3, α4 and β-strands D, F and
stabilized by interactions with the following residues: Trp105, Leu107, Gly113, Arg114,
Gly115, Arg118, Thr141, Asn145, Ser148 and Arg154. This CoA binding pocket is also
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conserved across the P. aeruginosa PA3270, PA4794 and PA2578 GNATs (Supplemental
Table 1).

Figure 1. Crystal structures of PA3944 in complex with CoA. (A) Monomer assigned to
orthorombic space group (PDB ID: 6edv). α helices (red) are labeled from α1 to α5, β
strands (yellow) from A to F and loops are shown in green. CoA is shown as spheres. (B)
The N-terminus (spheres) of one monomer (PDB ID: 6edd, chain B, yellow) is bound to
the active site of the other monomer (PDB ID: 6edd, chain B, blue). CoA is shown as
green sticks. The N- and C-termini are labeled as N and C in both panels.

We performed a structural similarity search of PA3944 against the PDB using VAST28 and
found the highest structural similarity toward two uncharacterized proteins from Bordetella
pertussis (PDB ID: 3juw, 24.2% sequence identity) and Bacillus halodurans (PDB ID:
2qml, 10.8 % sequence identity). The structure in the PDB that exhibited the highest
10

sequence identity is an uncharacterized acetyltransferase from Agrobacterium tumefaciens
(PDB ID: 2fsr, 32.2% sequence identity). We then used DALI29 to compare the PA3944
structure to all other known P. aeruginosa GNATs (Figure 2) and found the highest
structural similarity between PA3944 and the uncharacterized PA3270 protein (PDB ID:
1yre, 22.9% sequence identity). To determine whether we could predict the possible
function of PA3944 from sequence or structure, we broadened our search to include
GNATs that had been previously characterized from other organisms as described in
Supplemental Methods. Our comparison of the amino acid sequences of the acceptor
substrate binding sites of these proteins did not show any sequence similarity to PA3944;
therefore, we were unable to predict a possible native function for this enzyme based on
previously characterized GNATs. Moreover, we observed that the topology of the GNAT
structures were highly variable and the most similar proteins adopted different
conformations of some of their secondary structures (Figure 2). Thus, it was not feasible
to infer function from structure for the PA3944 enzyme.
Figure 2. Structural comparison of PA3944 with other GNATs from Pseudomonas
aeruginosa and other organisms with known functions. The structure of PA3944 is
shown in red and black on the left of the structure being compared. The putative acceptor
substrate binding region of PA3944 is shown in red and the CoA ligand is shown as black
spheres. The corresponding PDB ID is shown and gene names that correspond to the
PDB IDs are as follows: 1xeb (PA0115), 2fe7 (PA0478), 3owc (PA2578), 2cnm (RimI
from Salmonella typhimurium), 1yre (PA3270), 2j8r (PA4866), 4l8a (PA4794), 4r87
(SpeG from Vibrio cholerae), 2eui (PA4026), 2vi7 (PA1377), 4ubr (PA4534), and 4r9m
(SpeG from Escherichia coli).
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The only difference between our two PA3944 structures (P212121 PDB ID: 6edv, and P1
PDB ID: 6edd) was the presence of a portion of the N-terminus in the active site of the
adjacent monomer of the 6edd structure (Figure 1). Here, the histidine residue that remains
after tag cleavage and the first four residues of the protein (HMNAN) are observed in the
electron density and the δ-2 nitrogen of Asn2 from one chain forms a H-bond with the
backbone oxygen of Ser46 on a mobile loop of the second chain. In this conformation, the
-carbon atom of Met1 of the N-terminus bound in the active site of the opposite monomer
is 5.4 Å from the sulfhydryl group of CoA. Residues Met41-Leu48 on the loop between
helices α1 and α2 interact with the N-terminus and block the entrance to the active site.
The N-terminus of the 6edd structure was not modeled due to lack of electron density for
the first eight residues.
Since the PA3944 protein appeared to adopt two different oligomeric states (monomer and
apparent dimer) in the different crystals, we performed size-exclusion chromatography to
determine its oligomeric state in solution. We found the protein eluted as a monomer
regardless of pH (see Methods for more details; Supplementary Figure 1). This result is
consistent with PISA predictions30 which did not show any significant interactions between
monomers of the P1 (6edd) structure except those connected with binding a small portion
of the N-terminus. Therefore, we conclude that the PA3944 protein is a monomer in
solution and the observed binding of the N-terminus in the P1 (6edd) structure is a result
of crystal packing but may indicate that the protein is capable of binding a peptide or
peptide-like molecule. This is further supported by the fact that the closest sequence and
structural homologs with known function acetylate proteins (ribosomal protein alanine
acetyltransferase from Salmonella typhimurium, Uniprot ID Q8ZJW4_SALTY), or cyclic
peptides (FsC-acetyl coenzyme A N(2)-transacetylase from Neosartorya fumigate, Uniprot
ID SIDG_ASPFU) (Figure 3).
Figure 3. Pairwise sequence comparison between PA3944 and closest GNAT family
proteins with known functions. Sequences are colored according to pairwise similarity
from red (highly similar regions) to white (intermediately similar) to blue (highly
dissimilar). Similarity was calculated as BLOSUM62 scores averaged over three
residues. The CoA binding site in PA3944 is colored in orange, while its acceptor
substrate binding site is in orange. The sequences are labeled with Uniprot IDs.
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PA3944 acetylates polymyxin B and colistin on a single diaminobutyric acid residue
Polymyxins are polycationic macrocyclic antimicrobial peptides that have been isolated
from strains of the bacterium Bacillus polymyxa, and they disrupt the structure of the
bacterial cell membrane by interacting with its phospholipids. The most prevalent
polymyxins include polymyxin B (B1 and B2) and colistin (polymyxin E1 and E2). These
two families of polymyxins differ in their D-amino acid composition and in the fatty acids
that are attached to the N-terminus of the peptide. Both families contain identical L-amino
acid residues; however, polymyxin B also contains a D-phenylalanine residue whereas
colistin has a D-leucine residue in its place. The fatty acid composition varies for each type
of polymyxin, where polymyxin B1 and colistin E1 have a 6-methyloctanoyl group,
whereas polymyxin B2 and colistin E2 bear a 6-methylheptanoyl residue [reviewed in31].
Since polymyxins have five potential sites for N-acetylation on diaminobutryic acid (Dab)
residues within their structures (Figure 4), it was unclear whether the PA3944 enzyme
acetylated a single Dab or multiple Dabs on each antibiotic. Our initial hypothesis was that
the enzyme might acetylate Dab5 since it is located near the D-Phe/D-Leu of polymyxin
B/colistin and most closely resembles the structure of aspartame, but we could not rule out
the possibility that other Dabs might be modified. To determine the site(s) of acetylation
on polymyxin B and colistin, we performed the enzymatic acetylation reaction and
analyzed the products of the reaction using MS/MS. Product ion analyses of colistin and
polymyxin B indicate that predominant acetylation product of PA3944 is a singly
acetylated species and occurs only once on residue 3—the primary amine of the Dab
residue proximal to the macrocycle in both antibiotics.
Figure 4. Structures of polymyxins and substrate saturation curves for PA3944. The
structures of polymyxin B and colistin are shown in panels A and B, respectively. The
regioselective acetylation by PA3944 occurs on the Dab residue highlighted in red and
circled. AcCoA substrate saturation curves are shown in panel C at constant
concentration of polymyxin B (red circles) and colistin (black squares). The tagged
PA3944 protein is represented as filled circles or squares and the cleaved protein is
represented by open circles or squares. Polymyxin B and colistin substrate saturation
curves are shown in panel D at constant concentration of AcCoA. Coloring for
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polymyxin B, colistin, tagged, and cleaved protein is the same as panel C. Error bars
represent the standard deviation of triplicate reactions. See Methods for more details
regarding assay conditions.

Mass spectrometry analysis of the enzymatic reaction containing polymyxin B yielded a
singly acetylated polymyxin B1 (M+H)+ ion at m/z 1246.3 that was selected for product
ion analysis. Smaller abundances of singly-acetylated polymyxin ions containing sodium
were observed at m/z 1267.8 and m/z 1289.7 as well. The acetylated polymyxin B2 formed
ions in much smaller abundances (Supplemental Figure S2). No unmodified polymyxin
B1 or B2 were observed in this mass spectrum. The product ion spectrum of the singly
acetylated polymyxin B1 (m/z 1246.3; Supplemental Figure S3) shows an ion at m/z
904.8 formed by cleavage of the side chain resulting in the loss of a neutral fragment
containing the (unmodified) primary amine group that is farthest away from the cyclic
peptide ring. The product ion observed at m/z 762.4 is the cyclic peptide fragment formed
by loss of the side chain (analogous to the m/z 728.3 in the product ion spectrum of the
singly-acetylated colistin on Dab3 in Supplemental Scheme S1). Full scan MS analysis
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of the control reaction mixture containing polymyxin without PA3944 enzyme showed no
acetylated products.
Analysis of the enzymatic reaction containing colistin showed the singly acetylated colistin
E2 (M+H)+ ion at m/z 1197.8 and the singly acetylated (M+Na)+ E1 and E2 ions at m/z
1233.9 and m/z 1219.9, respectively (Supplemental Figure S4). A protonated molecular
ion from unmodified colistin E2 was observed at m/z 1155.8. Full scan MS analysis of the
control reaction mixture containing colistin without PA3944 enzyme showed no acetylated
products. The m/z 1197.8 ion, corresponding to a singly acetylated colistin E2, was
subjected to product ion analysis to determine the site of colistin acetylation
(Supplemental Figure S5). The cleavage of the colistin side chain produces an acylium
ion at m/z 997.4 (containing the acetyl group) formed by the loss of a fragment containing
the unmodified primary amine, closest to chain terminus, analogous to the m/z 904.8
observed in the product ion analysis of polymyxin. The formation of a product ion at m/z
728.3 corresponds to the unacetylated cyclic peptide fragment and demonstrates that the
acetyl modification is on the primary amine closest to the cyclic peptide (Dab3)
(Supplemental Scheme S2).
These results strongly suggest that the enzymatic reaction of PA3944 toward both
polymyxin B and colistin is specific for Dab3, the Dab residue proximal to the cyclic
peptide (Figure 4), as we did not observe multiple acetylation events on either of these
peptides under our described assay conditions. The colistin E2 isoform was the
predominant parent species as well as the predominant acetylated species observed in the
MS assays, while the relative abundance of polymyxins B1 and B2 were similar. Since
both E1/B1 and E2/B2 isoforms of the antibiotics were found to be acetylated, the
differences in fatty acid and D-amino acid composition does not appear to majorly affect
enzymatic acetylation of these substrates. Thus, the selectivity with respect to the location
of acetylation on both polymyxins was consistent. This enzymatic specificity is in contrast
to the nonselective chemical methods of acetylating polymyxin antibiotics, such as acetyl
chloride or acetic anhydride, which are very reactive and nonselective.
PA3944 exhibits similar catalytic efficiencies toward both polymyxin acceptor substrates
We kinetically characterized the PA3944 enzyme toward polymyxin B and colistin using
acetyl coenzyme A (AcCoA) as the acyl donor. Since polymyxin B and colistin structures
are quite similar (Figure 4), we expected the PA3944 enzyme would exhibit comparable
kinetic parameters toward both acceptor substrates. We found no major difference in the
catalytic efficiency of the enzyme toward polymyxin B or colistin when comparing tagged
or cleaved enzyme kinetic parameters (Table 2 and Figure 4). This indicates the
differences in fatty acid at the N-terminus and D-amino acid within the peptide sequence
of polymyxin B and colistin do not significantly alter PA3944 activity. Additionally, no
significant difference in catalytic efficiency was seen when AcCoA was varied and
concentrations of polymyxins were held constant regardless of whether the affinity tag was
present or removed. Thus, the presence of the affinity tag does not significantly alter
PA3944 enzymatic activity.
PA3944 is not an efficient diaminobutyric acid acetyltransferase
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Since PA3944 acetylated Dab3 on polymyxins, we wondered whether it would acetylate
free Dab amino acids more efficiently than those within the antibiotics. Dab
acetyltransferases, which are GNATs and part of the ectoine biosynthetic pathway, have
been studied from the halophilic bacteria Methylomicrobium alcaliphilum, Methylophaga
thalassica, Methylophaga alcalica, and Halomonas elongata.32-34 We found the apparent
affinity of PA3944 for Dab was 1-2 orders of magnitude lower (8.6 or 10 mM; tagged vs
cleaved, Table 2) than that reported for M. alcaliphilum, M. thalassica, and M. alcalica
(0.460, 0.365, and 0.375 mM, respectively33,34), and its catalytic efficiency was one order
of magnitude lower toward Dab compared to polymyxin B and colistin (Table 2).
Therefore, we concluded that under our described reaction conditions the PA3944 enzyme
is an inefficient Dab acetyltransferase and likely has an alternative native function.
PA3944 expanded substrate screening assays
To further explore substrate specificity of the PA3944 enzyme, we performed an expanded
screening assay with compounds denoted in Figure 5. Similar to our previous results, the
enzyme exhibited the highest activity toward aspartame, polymyxin B and colistin, but it
is not obvious why polymyxins and aspartame would be acetylated to a similar extent since
their structures are quite different. The previous substrate screen13 did not include a
complete series of compounds to evaluate which structural components of these molecules
are important for PA3944 recognition. Therefore, we selected compounds that were
commercially available to determine structural elements necessary for acetylation of
aspartame and polymyxins (Figure 5). First, we focused on molecules that represented
structural components of aspartame. We found L-glutamate, L-aspartate, glycine, and
alanine are very poor substrates for the PA3944 enzyme. Limited activity was observed for
substrates bearing an aminoethyl group (taurine, carnosine, and diaminobutyric acid);
however, beta-alanine, which also contains an aminoethyl group, was a poor substrate. This
indicates that there are structural elements in aspartame that are more favorable for
acetylation than the simpler amine containing substrates we assayed (Figure 5). We are
currently in the process of synthesizing aspartame analogs to learn more about the
structural elements of aspartame that are recognized by PA3944.
Figure 5. Substrate screening of PA3944. Average activity of PA3944 from triplicate
reactions toward each substrate is shown and more details of assay conditions are found in
Methods. Structures of each substrate are overlaid onto the bar graph with the site of
acetylation highlighted in red. Only partial structures of polymyxin B and colistin are
shown. Full structures of these compounds can be found in Figure 4. Error bars represent
the standard deviation of triplicate reactions.
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Next, we turned our attention to PA3944 activity toward polymyxin B and colistin. Both
polymyxins contain diaminobutyric acid residues; therefore, we investigated the
importance of chain length between the alpha carbon and primary amine by comparing
activity toward free amino acids glycine, L-alanine, 2,3-diaminopropionic acid (Dap), 2,4diaminobutyric acid (Dab), L-ornithine, and L-lysine (Figure 5). We found the optimal
distance between the alpha carbon and the primary amine was the presence of two
methylenes, like that of Dab. Therefore, we performed substrate saturation curves for Dab
and found that the catalytic efficiency was one order of magnitude lower for the single free
Dab residue than when it is incorporated into the cyclic peptide of polymyxin B or colistin
(Table 2). This indicates that differences in charges of substrates or additional interactions
between the enzyme and polymyxin substrates enhance activity and are important for
substrate specificity.
Polymyxin acetylation is enzymatic and optimal activity occurs at pH 8
GNATs use a general acid/base catalytic mechanism to acetylate their acceptor substrates.
This occurs when the enzyme deprotonates a primary amine of an acceptor substrate using
either an acidic active site residue or water molecule, and then a residue like tyrosine is
used to reprotonate CoA after acetyltransfer. As the pH of the buffer used for enzymatic
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assays increases, there is a higher likelihood that the acceptor substrate is already
deprotonated and would cloud whether or not the observed reaction is indeed enzymatic.
Therefore, to ensure that the polymyxin acetylation reaction we observed was enzymatic,
we performed a series of kinetic assays in different buffers and at different pHs. First, we
measured the kinetic activity of PA3944 toward polymyxin B in the presence of Tris-HCl
pH 8.0 or Bis-Tris-propane pH 8.0 buffer and compared the kinetic parameters (Figure
6A). We found the catalytic efficiency of the enzyme in Tris-HCl pH 8.0 and Bis-Trispropane pH 8.0 was 2.47x102 M-1s-1 and 7.33 x 102 M-1s-1, respectively, indicating the
catalytic efficiency of the enzyme in Bis-Tris-propane buffer is nearly 3-fold higher than
in Tris-HCl. Next, we performed substrate saturation curves toward polymyxin B in BisTris-propane buffer at different pHs (Figure 6B). The activity of the enzyme varied with
pH and did not continue to increase linearly at higher pH, which would be expected if nonenzymatic acetylation were occurring. We found the enzymatic activity toward polymyxin
B at different pHs exhibited a gaussian curve (Figure 6C) with a pH optimum at 8.0. This
type of curve matches what would be expected for a general acid/base catalytic mechanism
where two residues are likely participating in the reaction. Additional plots of log Vmax as
a function of pH, log Km as a function of pH, and log kcat/Km as a function of pH are
presented in Supplemental Figure S6. Note that substrate saturation curves at pH 6.5 and
7.0 (Figure 6B) did not reach saturation, so the apparent Vmax and Km values used to
produce the curves in Supplemental Figure S6 may affect data interpretation. Overall, our
results provide evidence that the polymyxin acetylation reaction is indeed enzymatic.
Studies to identify these critical residues for enzymatic activity are currently underway in
our laboratory.
Figure 6. PA3944 activity toward polymyxin B in different buffers and pHs. A)
Comparison of polymyxin B substrate saturation curves at constant concentration of
AcCoA (0.5mM) in Tris-HCl and Bis-Tris propane buffers at pH 8.0. Data were fit using
non-linear regression as described in materials and methods. B) Polymyxin B substrate
saturation curves as a function of pH in Bis-Tris propane buffers from pH 6.5-9.5. Data
were fit using non-linear regression as described in materials and methods. C) PA3944
activity toward 2 mM polymyxin B and 0.5 mM AcCoA in Bis-Tris propane buffers at
pH 6.5, 7.0, 8.0, 9.0, and 9.5. Data were fit to a gaussian curve. See materials and
methods for further details.
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Polymyxins are heterogeneous and may affect reproducibility
Since commercial polymyxins are heterogeneous mixtures of fermentation products
isolated from bacteria and they can adhere to polystyrene, it is important to note that
different preparations of solutions of these molecules may vary in composition from batch
to batch [reviewed in35]. While this potentially presents challenges for interpreting and
reproducing kinetic parameters from different laboratories, in our hands two different
PA3944 enzyme preparations and polymyxin B preparations were used to collect the
enzyme kinetic assay data in Figures 4-6. We observed differences in kcat and Km from the
two preparations; however, the catalytic efficiencies of the enzymes were nearly identical.
Thus, catalytic efficiencies may be the more useful parameter for comparing PA3944
enzymatic activity in the future from lab to lab.
The non-native function of PA3944 could be exploited for biotechnology applications
Due to the rise in antibiotic resistance toward most antibiotics, polymyxins are being used
as a last resort to treat multi-drug resistant or extreme drug resistant bacterial infections
[see reviews31,36]. While we have shown that PA3944 can acetylate polymyxin antibiotics
in vitro, we do not think this is its physiological function. The rationale for our conclusion
is primarily based on the fact that the apparent affinity of PA3944 for both polymyxins is
in the millimolar range (Table 2) and reported breakpoints for polymyxin B or colistin for
P. aeruginosa resistance to these antibiotics is in the micromolar range (greater than or
equal to 4 g/mL (~3 M) for colistin and 8 g/mL (~6 M) for polymyxin B35). While it
is unlikely that the native function of PA3944 is to modify polymyxins, its ability to singly
acetylate Dab3 on the fatty acyl tail of these important antibiotics could be exploited. For
instance, in vitro chemical mechanisms of acylation of polymyxins are promiscuous, and
having a controlled acylation method for modifying these antibiotics enables specific
chemical transformations of these important molecules. Additionally, future directed
evolution of the PA3944 enzyme may allow for selective acylation of other sites of these
types of antibiotics, which could significantly improve synthetic strategies of these
molecules. Furthermore, if the PA3944 enzyme is able to recognize other antimicrobial
peptides in a similar manner, it could also be used to selectively modify structurally similar
octapeptin antimicrobial peptides. While the native function of PA3944 remains unknown
and warrants further investigation, the regioselectivity of this enzyme may be exploited for
future biotechnological applications (e.g. designing reporters) and/or drug development.
Supporting Information
Supplemental Methods for protein expression and purification for crystallization, protein
crystallization, size-exclusion chromatography, and sequence and structural comparison of
homologs. Supplemental Results including mass spectrometry of acetylated polymyxin B
and colistin. Supplemental Table S1, Figures S1-S6, and Schemes SC1, SC2.
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SUPPLEMENTAL METHODS
Materials
Acetyl coenzyme A (AcCoA; #A2181) and coenzyme A (CoA; #C3019) trilithium salts, and
polymyxin B (#P4932) and colistin (#C4461) sulfate salts were purchased from Sigma-Aldrich.
All other reagents for biochemical assays were purchased at the highest quality available.
Protein expression and purification for crystallization
The ampicillin resistant plasmid containing the PA3944 gene was transformed into
chloramphenicol resistant E. coli BL21(DE3) CodonPlus-RIL cells (Agilent). A starter culture of
LB with 100 µg/ml ampicillin and 34 µg/ml chloramphenicol was inoculated and grown overnight
at 37°C at 200 rpm. The following morning 10 ml of starter culture was used to inoculate 1 L of
LB. Cells were grown until the OD600nm reached 0.8 and then cooled to 16°C. Protein expression
was induced with 1 mM IPTG and expressed overnight at 16°C with shaking. The next day, the
cells were harvested by centrifugation (25 min at 4000 x g at 4°C in a Beckman Coulter Avanti J26 XP centrifuge) and the supernatant was discarded. The pellet was resuspended in lysis buffer
(50 mM Tris-HCl pH 7.8, 2 mM imidazole, 150 mM sodium chloride) and homogenized in a glass
homogenizer. One tablet of protease inhibitor (cOmplete Mini, EDTA-free Protease Inhibitor
Cocktail Tablets, Roche) and a pinch of lysozyme (Sigma product # L-6876) and 2 µl of Benzonase
Nuclease (Sigma product # E1014) were then added to the cell suspension, sonicated on ice, and
centrifuged (45 min at 142,400 x g, and 4°C in a Beckman Coulter Optima L-80 XP
ultracentrifuge). The supernatant was loaded onto a gravity flow Ni-NTA column (Qiagen)
previously equilibrated with lysis buffer and the flow-through was collected and reapplied on the
column three times to extend the length of interaction time between the protein and resin. The resin
was then washed with wash buffer (50 mM Tris-HCl pH 7.8, 10 mM imidazole, 600 mM sodium
chloride) and protein was eluted with elution buffer (50 mM Tris-HCl pH 7.8, 250 mM imidazole,
200 mM sodium chloride). To remove the polyhistidine tag, the eluted protein was combined with
tobacco etch virus (TEV) protease in a 15:1 ratio and dialyzed in a 10 kD MWCO Slide-A-Lyzer
dialysis cassette (Thermo Fisher Scientific) against 1 L of dialysis buffer (50 mM Tris-HCl pH
7.8, 150 mM sodium chloride, 14 mM BME) overnight at 4°C. The dialyzed protein was loaded
onto the nickel-affinity column that had been equilibrated with dialysis buffer. The flow-through
was collected, concentrated with an Amicon Ultra Centrifugal Filter with a 10K MWCO, and
loaded onto a HiLoad 16/60 Superdex 200 gel filtration column using an AKTA FPLC (GE
Healthcare) in 100 mM Tris-HCl pH 7.5 and 150 mM NaCl buffer. Polyhistidine tag cleavage was
confirmed by SDS-PAGE.
Protein crystallization
The PA3944 protein was crystallized using hanging drop vapor diffusion at 16°C in 3-Well Midi
Crystallization plates (Swissci) that were set using a Mosquito crystallization robot (TTP Labtech).
Crystals used for data collection and structure determination were from two different preparations
of protein but in the same crystallization condition (MCSG1 screen, well C11: 100 mM Tris-HCl
pH 7.0, 200 mM calcium acetate monohydrate, 20%w/v PEG 3000): 1) cleaved PA3944 protein
at 14 mg/ml co-crystallized in the presence of 5 mM puromycin and CoA with a ratio of protein
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to mother liquor of 1:1; ethylene glycol was used as a cryoprotectant. 2) cleaved PA3944 protein
at 10 mg/ml co-crystallized in the presence of 5 mM colistin and CoA with a ratio of protein to
mother liquor of 3:2; no cryoprotectant was added when harvesting crystals for data collection.
Crystals were harvested using Hampton CryoLoops and dried for 10-15 minutes over 1 M sodium
chloride (a slow dehydration technique) and then frozen in liquid nitrogen.
Size-exclusion chromatography
The oligomeric state of the PA3944 protein was determined using size exclusion chromatography
with a HiLoad 16/60 Superdex 75 gel filtration column (GE Healthcare). A calibration curve was
prepared from retention times and molecular weights of albumin (66.5 kDa), ovalbumin (44.3
kDa), chymotrypsin (25 kDa) or ribonuclease A (13.7 kDa) in 100 mM Tris-HCl pH 7.0 buffer.
To determine whether pH affected the oligomeric state of the PA3944 protein, separate
measurements were determined in the following buffers that contained 150 mM NaCl: 100 mM
potassium phosphate pH 6.0; 100 mM Tris-HCl at pH 7.0 or 8.0; and 100 mM CHES at pH 9.0.
We also assessed whether the presence of AcCoA affected the oligomeric state of PA3944 by
analyzing the retention times of the PA3944 protein in the presence of a 2-fold excess of AcCoA:
protein. 15 nmol of protein was injected onto the column at a flow rate of 1.5 ml/min for each
measurement.
Sequence and structural comparison of homologs
To identify PA3944 homologs, we queried the SwissProt database using the PA3944 sequence and
single iteration BLAST (E-value cutoff of 10). From these results, we selected sequences of
proteins with 3D structures and experimentally verified functions or preliminary substrates. These
included two polyamine acetyltransferases (Uniprot IDs ATDA_VIBCH and ATDA_ECOLI) and
a fusarinine C siderophore acetyltransferase (Uniprot ID: SIDG_ASPFU)1-3. Two sequences of
protein acetyltransferase RimI from E. coli and S.typhimurium (Uniprot IDs Q8ZJW4)SALTY,
RIMI_ECO57, respectively) and three sequences of GNAT acetyltransferases from P. aeruginosa
(Uniprot IDs: Q9HUU7, and Q9HV14) that have been found to acetylate L-methionine
sulfoximine and L-methionine sulfone4, and a C-terminal lysine residue of a peptide5, respectively,
as well as UniProt ID: Q9I0Q8, which was included in our broad substrate screening6 but does
not have a known function. The sequence alignment (Figure 3) was performed using the program
PROMALS3D7,8. A structural alignment of all GNATs from P. aeruginosa with crystal structures
was performed using secondary-structure-matching (SSM) with the program SUPERPOSE from
the CCP4 suite9. The acceptor substrate binding site in all structures was visually identified.

SUPPLEMENTAL RESULTS
Mass spectrometry of acetylated colistin and polymyxin B
Molecular weight and product ion spectra were acquired from each reaction mixture.
Product ion analyses of colistin and polymyxin indicate that the primary site of enzymatic
acetylation occurs (just once) on the primary amine on the side chain closest to the cyclic peptide
at the end of the chain. Molecular weight analysis of reaction mixtures containing AcCoA and
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polymyxin in presence and absence of enzyme are shown in Figure S2. These spectra strongly
suggest polymyxin acetylation only occurs in the presence of the PA3944 enzyme. In Figure S2A,
(M+H)+ and (M+Na)+ ions formed from polymyxin B1 are observed at m/z 1204 and m/z 1226
and those for polymyxin B2 are observed at m/z 1190 and m/z 1211, respectively. No acetylated
polymyxin ions are observed in the spectrum of the control reaction in absence of enzyme. Figure
S2B shows monoacetylated polymyxin B1 at m/z 1246 (M+H)+, m/z 1268 (M+Na)+, and m/z 1290
(M-H+2Na)+, respectively. No multiply acetylated polymyxin molecules are observed.
Product ion spectra of the (M+H)+ ion at m/z 1246 formed from the monoacetylated
polymyxin is shown in Figure S3. An ion observed at m/z 904.8 is formed by cleavage on the side
chain resulting in the loss of a neutral fragment containing the (unmodified) primary amine that is
farthest away from the cyclic peptide ring. The m/z 904.8 fragment ion contains the acetyl group.
The product ion observed at m/z 762.4 is the cyclic peptide fragment formed by loss of the side
chain analogous to the m/z 728.3 in the product ion spectrum of the singly-acetylated polymyxin
B in Figure S3 (see also Scheme S1). If polymyxin B was acetylated on the primary amine closest
to the end of the fatty acyl chain (Dab1) we would expect to see an ion at m/z 863. This ion is not
observed, so we conclude that the primary amine closest to the peptide ring in polymyxin is the
main site of acetylation.
Molecular weight analysis of reaction mixtures containing AcCoA and colistin in the
presence and absence of enzyme are shown in Figure S4. Spectra of the control reaction show
(M+H)+ and (M+Na)+ of unacetylated colistin E2 (m/z 1156 and m/z 1178) and colistin E1
molecules (m/z 1170 and m/z 1192), respectively (Figure S4A). Ions formed from monoacetylated
colistin E2 are observed in Figure S4B at m/z 1198 (M+H)+ and m/z 1220 (M+Na)+. A smaller
abundance of the (M+Na)+ formed from monoacetylated colistin E1 is observed at m/z 1234. These
spectra strongly suggest the acetylation of colistin only occurs in the presence of the PA3944
enzyme. No m/z values consistent with the (M+H)+ and (M+Na)+ ions formed from multiply
acetylated colistin are observed. We do not know the identities of the additional ions observed at
m/z 1313, 1327, and 1449 but each appear to become acetylated in the presence of the enzyme due
to the observation of ions at m/z 1356, 1370, and 1491. Since colistin sulfate is supplied as a
mixture of molecules, we cannot conclusively state the identity of these ions; however, it is clear
that the apparently acetylated molecules are only observed in the presence of the PA3944 enzyme.
The protonated molecule ion at m/z 1198 was subjected to product ion analysis (Figure S5)
to locate the position of acetyl modification on the colistin molecule (Scheme S2). The product
ion spectra suggest that the primary position of acetylation is on the primary amine on the side
chain closest to the peptide ring. The observation of an acylium ion formed by the cleavage of
colistin produces an ion at m/z 997.4 (containing the acetyl group) that is formed by the loss of a
fragment containing the unmodified primary amine farthest away from the cyclic peptide ring. The
formation of a product ion at m/z 728.3, corresponding to the unacetylated cyclic peptide fragment,
strongly suggests that acetylation occurs on the primary amine closest to the cyclic peptide
(Scheme S2). Modification of the amine closest to the end of the peptide chain would have yielded
an acylium ion at m/z 955 formed by the loss of a fragment containing the acetyl group and this
ion is not observed in any significant abundance. Therefore, we conclude the primary amine closest
to the peptide ring is the principal site of modification.
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SUPPLEMENTAL TABLES, FIGURES, and SCHEMES
Table S1. Summary of Pseudomonas aeruginosa GNAT genes, proteins, and structures.
Pseudomonas gene
PA0115
PA0249
PA0478
PA0483
PA0711
PA1062
PA1377
PA1428
PA1472
PA1749
PA1885
PA1928
PA1943
PA2271
PA2578
PA2631
PA3127
PA3248
PA3270
PA3368
PA3460
PA3944
PA3945
PA4026
PA4114
PA4166
PA4166
PA4534
PA4678

PA4794
PA4863
PA4866
PA5204
PA5432
PA5433
PA5475

UniProt ID
Q9I717
Q9I6P0
Q9I640
Q9I635
Q9I5L7
Q9I4R2
Q9I3W7
Q9I3R6
Q9I3P0
Q9I2Y8
Q9I2L2
Q9I2H6
Q9I2G1
Q9I1K2
Q9I0Q8
Q9I0K7
Q9HZ97
Q9HYZ2
Q9HYX1
Q9HYN3
Q9HYE6
Q9HX72
Q9HX71
Q9HX01
Q9HWR6
Q9HWL5
Q9HWL5
Q9HVP3
Q9HVB7

Q9HV14
Q9HUV0
Q9HUU7
P22567
Q9HTD4
Q9HTD3
Q9HT95

PDB IDs of crystal structures

1xeb
2fe7

2vi7

3owc

1yre

2eui

4ubr, 5ib0
3kkw, 4kot, 4oae, 4l8a, 4oad, 4kub, 4klw, 4kow, 4klv,
4kua, 4kov, 4l89, 4kos, 4kor, 4kou, 4koy, 3pgp, 4m3s,
4kox
1yvo, 2j8m, 2j8n, 2j8r, 2bl1

* Based on predictions from InterPro, each protein listed is either annotated as a GNAT or contains a
GNAT domain.
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Figure S1. Size exclusion chromatograms of PA3944 protein with different buffers in the absence
(apoenzyme) and presence of AcCoA (haloenzyme) (A), calculated molecular weights (B), and
calibration curve (C). See Methods for more specific details.
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Figure S2. Full scan ESI mass spectrum of a reaction mixture containing polymyxin B and AcCoA in A)
absence of PA3944 enzyme and B) presence of PA3944 enzyme. The electrospray mass spectra of the
polymyxin peptide mixture (Figure S2A) show protonated (M+H)+ and cationized (M+Na)+ molecule
ions generated from form B1 at m/z 1203.9 and at m/z 1225.8, respectively. Smaller abundances of the
protonated molecule ion formed from the B2 form are observed at m/z 1189.7. No acetylated products
are observed without the enzyme present in the reaction mixture. When the enzyme is present in the
reaction mixture (Figure S2B) only ions generated from the acetylated polymyxin are observed.
Protonated molecule ions from the B2 and B1 forms modified by single acetyl groups are observed at m/z
1231.3 and m/z 1245.3. Ions containing one (M+Na)+ and two sodium ions (M+2Na)+ are formed from
the B1 containing one acetyl group are observed at m/z 1267.8 and m/z 1289.7. No unmodified
polymyxin or polymyxin molecules modified by multiple acetyl groups are observed in the Figure 2B
spectra. See Methods for more specific details about sample preparation (positive ion mode).
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Figure S3. Product ion mass spectra of the protonated molecule ion of A) unmodified polymyxin B that
was observed at m/z 1204 and B) polymyxin containing one acetyl group that was observed at m/z 1246
(positive ion mode), showing loss of water as the primary fragmentation in both cases.
(M+H‐H2O)+

(M+H‐H2O)+

B
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Figure S4. Full scan ESI mass spectra of a reaction mixture containing colistin A and B and AcCoA A)
in the absence of PA3944 enzyme and B) in the presence of PA3944 enzyme. See Methods for more
specific details about sample preparation (positive ion mode).
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Figure S5. Product ion mass spectra of the protonated molecule ion of A) unmodified colistin that had
been observed at m/z 1156 and B) of the colistin ion containing one acetyl group (positive ion mode) that
had been observed at m/z 1198. Loss of water was observed as the primary fragmentation in both cases.
(M+H‐H2O)+

(M+H‐H2O)+
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Figure S6. PA3944 pH profiles with polymyxin B as acceptor substrate. A) log kcat/Km (M-1s-1) as a
function of pH, B) log Km (mM) as a function of pH, and C) log Vmax (mol/min/mg) as a function of pH.
Kinetic parameters used for the plots were calculated from non-linear regression fittings of the substrate
saturation curves in Figure 6B to the Hill equation as described in materials and methods.
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Scheme S1. Product ion formation indicative of the position of acetyl group attachment in the enzyme
catalyzed acetylation of polymyxin B.
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Scheme S2. Product ion formation process indicative of the position of acetyl group attachment in the
enzyme catalyzed colistin acetylation.
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